Produktinformation
Name:
Ranitidine Bismuth Citrate
Synonyme:
- 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-, compd. with 2-hydroxy-1,2,3-propanetricarboxylic acid bismuth(3+) salt (1:1:1)
- 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) salt, compd. with N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine (1:1:1)
- Gastrimuto
- Gr 122311X
- Pylorid
- Ranitidine bismutrex
- Rantidinebismuthcitrate
- Tritec
- bismuth(3+) 2-hydroxypropane-1,2,3-tricarboxylate - (Z)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine (1:1)
Beschreibung:
Ranitidine bismuth citrate is a histamine H2 receptor antagonist that has been shown to be effective in the treatment of infectious diseases. It is also used as a prophylactic agent against stress-induced ulcers, and as an adjunct in the treatment of duodenal ulceration. Ranitidine bismuth citrate has a low solubility at physiological pH values and is often formulated with citric acid or sodium bicarbonate to increase solubility. The drug's mechanism of action is not fully understood but it is believed to be due to its ability to bind histamine receptors on the surface of the stomach lining, thereby reducing acid production by parietal cells in the stomach. Ranitidine bismuth citrate may also inhibit growth factor-β1 (GF-β1) synthesis.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
712.49 g/mol
Formel:
C13H22N4O3S·C6H5O7·Bi
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
